Bobby Sandage - Profile and Investment Details

Investor Profile

Bobby Sandage is a Venture Capital, Investor based in St. Louis, Missouri, United States with a diverse investment portfolio that includes companies such as BioVentures, LLC, AI Proteins, American Critical Care, Geneoscopy, Osteologix Inc., Predicta Biosciences, NextRNA Therapeutics, Microbial Machines, Vasculox, Edis Solutions, Endevica Bio, Immunophotonics Inc, Gentium SpA, Endevica (formerly known as TENSIVE CONTROLS, INC.), Mateon Therapeutics, . Over time, Bobby Sandage has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Bobby Sandage is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Drug Discovery, Messaging, Wellness, Women Founded, Immunotherapy, Fundraising, HR Tech, CRM, Engineering, Texting Platforms, Banking, Southeast Asian Founded, Education, Artificial Intelligence (AI), Information Technology (IT), Analytics, 3D Technology, Mobile, Finance, Software, Biotechnology, Hispanic / Latinx Founded, Virtual Reality, Clinical Trials, FinTech, Consumer Internet, Insurance, Marketing, Personalized Medicine, Lending, Medical, SaaS, B2B, Short Message Service (SMS), Molecular Diagnostics, Machine Learning, Speech Recognition, Pharmaceuticals, South Asian Founded may find it worthwhile to explore potential connections with Bobby Sandage, as their portfolio suggests a familiarity and interest in this area.

Understanding Bobby Sandage’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.